Patrick McLeroth

Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection

Christopher Lucasti, Liviu Vasile, Dorel Săndesc et al. · Antimicrobial Agents and Chemotherapy · 2016 · 177 citations · Full text

Klebsiella Pneumoniae, Antimicrobial Chemotherapy, Dose-ranging Study +22

Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

Matthew Sims, Valeri Mariyanovski, Patrick McLeroth et al. · Journal of Antimicrobial Chemotherapy · 2017 · 158 citations · Full text

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

Michael S. Niederman, Jeff Alder, Matteo Bassetti et al. · The Lancet Infectious Diseases · 2019 · 125 citations

Superiority Trial, Pulmonary Care, Antibiotics +7

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

Florian Wagenlehner, Leanne B. Gasink, Paul C. McGovern et al. · New England Journal of Medicine · 2024 · 95 citations

[124I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection

Xiaoyan M. Zhang, Halle H. Zhang, Patrick McLeroth et al. · Nuclear Medicine and Biology · 2016 · 55 citations · Full text